The association between F3/F4 fibrosis and the liver fibrosis score (LFS) algorithm was improved by inclusion of the CD14+ or CD16+ leukocyte EV frequency, each of which also improved the risk prediction of F3/F4 fibrosis in NAFLD [300]. This evidence concerns the gene CD14 and fibrosis.